Market

TCS vs Infosys: India’s leading IT companies, Tata Consultancy Services (TCS) and Infosys, key constituents of the Nifty IT index, have recently announced their fourth-quarter results, sparking considerable discussion across the Indian equity market. With both firms reporting their earnings, several brokerages, including Nuvama and HDFC Securities, have shared their assessments, offering a mixed outlook…

Ex-date stocks today, April 24: Shares of several companies, including Anlon Healthcare, HCL Technologies, Patanjali Foods, Mold-Tek Packaging, String Metaverse, Vega Jewellers and Windlas Biotech will trade ex-date on April 24, 2026, as investors track dividend payouts, bonus issues, stock splits and share buybacks. Among today’s ex-date stocks, HCL Technologies Ltd is offering the highest…

Reliance Industries is expected to deliver a mixed set of earnings in the fourth quarter of FY26, with steady growth in its consumer‑facing businesses offset by pressure in the oil‑to‑chemicals (O2C) segment amid global geopolitical disruptions. Consolidated revenue is likely to rise sequentially on the back of continued momentum in Reliance Jio and modest growth…

The stock market witnessed notable movements today as several stocks stood out with significant gains and losses. Among the top gainers, Coal India Ltd, Nestle India Ltd and Grasim Industries Ltd surged sharply, driven by positive sectoral trends, or favorable market sentiment. These stocks outperformed broader indices, attracting investor interest and heavy trading volumes.On the…

Buy, Sell or Hold: Brokerage firm Citi has shared its latest view on Hyderabad-based multinational pharmaceutical stock Dr Reddy’s Laboratories. The firm maintains a ‘sell’ rating with a target price of Rs 1,070. Here are the reasons why the brokerage firm maintains the sell rating. According to the brokerage, Dr Reddy’s stock price surged approximately…

LTM Ltd share price target: (LTIMindtree) share price fell 3.4 per cent to hit an intraday low of Rs 4,376 apiece as of 09:21 AM after brokerage views remained largely unchanged on the company’s outlook following its Q4FY26 result. LTIMindtree’s Q4FY26 performance reflected a mixed operating environment, with steady revenue growth and healthy deal wins…

Founded in 1935, Cipla has a major presence across India, South Africa, and North America. The company has 46 advanced manufacturing hubs, producing over 1,500 products. Its key segments span across respiratory, anti-retroviral and cardiology. Recognised for its role in making HIV/AIDS treatment affordable and inclusive, Cipla has a market cap of over Rs 1…

Tata Capital stock in focus: Brokerages give ‘Add’ call after Q4 results, revise target price – Key reasons inside (Image: Canva/ET Now Digital) No stock data available Tata Capital stock in focus: Brokerage firm, HDFC Securities, maintains an ‘ADD’ rating on Tata Capital while revising the target price to Rs 335. Tata Capital announced its…

Stocks to BUY, SELL or HOLD Today, April 24: Brokerages offered a mixed outlook on equities on April 24, with buying interest seen in IT majors like Infosys and LTIMindtree, while healthcare names such as Dr Reddy’s Laboratories faced bearish calls; asset managers including Aditya Birla Sun Life AMC and UTI Asset Management Company saw…

Written by: Heena Ojha Updated Apr 24, 2026 08:15 IST Infosys’ FY27 revenue guidance at 1.5–3.5 per cent YoY below expectations reflecting macro uncertainty. (Image: iStock/ ET Now Digital) No stock data available Infosys’ Q4FY26 results came largely in line with expectations, but brokerages turned cautious on the stock after management flagged slower growth ahead….